BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 29/05/2024

FDA Announces Availability of Draft Guidance for Platform Technology Designation Program

The Food and Drug Administration is releasing a draft guidance document outlining the details of the Platform Technology Designation Program for drug development, established by the PREVENT Pandemics Act, to provide clarity on eligibility, benefits, and the designation process.

Source: Federal Register — Food and Drug AdministrationOpen original release →